Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2009-01-01
2017-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with ischemic heart disease
Patients with ischemic heart disease scheduled for myocardial perfusion scintigraphy were enrolled. Biomarkers were analysed form periferal blood. Patients outcome data were followed up to 5 years.
myocardial perfusion scintigraphy
Myocardial perfusion scintigraphy as it is described in the international literature.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
myocardial perfusion scintigraphy
Myocardial perfusion scintigraphy as it is described in the international literature.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pecs
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tihamér Molnár
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tihamer Molnar, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pecs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pecs
Pécs, Baranya, Hungary
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Molnar T, Horvath A, Szabo Z, Vamos Z, Doczi T, Illes Z. Detection of silent cerebral microcirculatory abnormalities in patients with manifest ischemic coronary disease: a perfusion brain MRI study combined with dipyridamole stress. Scand Cardiovasc J. 2021 Apr;55(2):97-101. doi: 10.1080/14017431.2020.1821911. Epub 2020 Sep 18.
Related Links
Access external resources that provide additional context or updates about the study.
Regulation of Coronary Blood Flow in Health and Ischemic Heart Disease
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PTE3950
Identifier Type: -
Identifier Source: org_study_id